FMR GLOBAL HEALTH · STRATEGIC ADVISORY
Where is the opportunity — and can you win it?
Market size is only the starting point. We help pharma, biotech and medtech teams understand attractiveness, competition and ability to win, so they can prioritise the right growth opportunities.
Evidence-led.
Senior-led.
Decision-ready.
Clarity for healthcare business decisions.
Decisions we support
Which markets, indications or segments should we prioritise? Is the opportunity worth the investment? What competitive or access barriers could change the answer? Should we build, partner, enter later or walk away?
Assess opportunity from several angles
Depending on the decision, we integrate epidemiology and patient flows, market and treatment data, access and pricing dynamics, unmet needs, stakeholder insight and competitor pipelines. We make assumptions visible and develop scenarios rather than relying on one headline number.
Translate evidence into strategic choices
We assess attractiveness against your capabilities, commercial objectives and constraints; compare plausible routes to growth; and collaborate through senior-led discussion or workshops to shape prioritised recommendations.
What your team can use
An opportunity map • Defensible market-size scenarios • Competitive landscape and risk assessment • Prioritised growth options • Strategic implications and recommended next steps.